Literature DB >> 574823

Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency.

M Ranke, B Weber, J R Bierich.   

Abstract

The results of long term treatment with human growth hormone (Crescormon, 12.4 IU/m2/week) in 36 patients with idiopathic growth hormone deficiency are given. Birth trauma--in particular assisted breech delivery (30%)--is the major aetiological cause. Twelve patients had isolated growth hormone deficiency (IGHD), 24 had multiple pituitary hormone deficiencies (MPHD) of which 19 were treated with additional thyroid hormones. The results were judged by the criteria of height velocity, total height gain and change of height prediction (TW2, age based). It is concluded that the growth hormone dose chosen in many cases is insufficient to maintain high growth rates after the first year of treatment, when "catch-up" no loner takes place. The tendency of patients supplemented with thyroid hormone to grow better--without additional bone-age advancement--calls for careful search for hypothyroidism and suggests the use of thyroxin in cases of doubt.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574823     DOI: 10.1007/bf00496846

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Preparation and properties of growth hormone from human and monkey pituitary glands.

Authors:  C H LI; H PAPKOFF
Journal:  Science       Date:  1956-12-28       Impact factor: 47.728

2.  Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards.

Authors:  N BAYLEY; S R PINNEAU
Journal:  J Pediatr       Date:  1952-04       Impact factor: 4.406

3.  Vasopressin test: diagnostic inaccuracy in evaluation of hypothalamic-pituitary-adrenocortical axis.

Authors:  S Leisti; J Perheentupa
Journal:  Acta Endocrinol (Copenh)       Date:  1978-01

4.  [Diagnosis and treatment of hypopituitary dwarfism (author's transl)].

Authors:  D Schönberg
Journal:  Monatsschr Kinderheilkd       Date:  1973-10

5.  Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.

Authors:  M H MacGillivray; M Kolotkin; R W Munschauer
Journal:  Pediatr Res       Date:  1974-02       Impact factor: 3.756

6.  Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism.

Authors:  J A Grunt; A R Enriquez; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1972-07       Impact factor: 5.958

Review 7.  Human growth hormone and hypopituitargrowth retardation.

Authors:  O Trygstad
Journal:  Acta Paediatr Scand       Date:  1969-07

8.  Growth and growth hormone. I. Changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation.

Authors:  S L Kaplan; C A Abrams; J J Bell; F A Conte; M M Grumbach
Journal:  Pediatr Res       Date:  1968-01       Impact factor: 3.756

9.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

View more
  11 in total

Review 1.  Optimization of growth hormone therapy in growth hormone deficient children.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

Review 2.  Height matters-from monogenic disorders to normal variation.

Authors:  Claudia Durand; Gudrun A Rappold
Journal:  Nat Rev Endocrinol       Date:  2013-01-22       Impact factor: 43.330

3.  The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children.

Authors:  M Bozzola; G Radetti; S Pagani; M Draghi; G Aimaretti; G Rondini
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

4.  Growth hormone deficiency--current problems.

Authors:  M A Preece
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

Review 5.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

6.  The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases.

Authors:  H L Lenko; S Leisti; J Perheentupa
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

7.  Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.

Authors:  M B Ranke; M Gruhler; R Rosskamp; G Brügmann; A Attanasio; W F Blum; J R Bierich
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

8.  Longitudinal anthropometric measurements in patients with growth hormone deficiency. Effect of human growth hormone treatment.

Authors:  W Sorgo; M Zachmann; D Tassinari; F Fernandez; A Prader
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

Review 9.  Development, production and pharmacodynamics of human growth hormone.

Authors:  J T Jørgensen; T Chirstensen; M Jørgensen; G Jakobsen
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

10.  Human growth hormone therapy: longterm responses in 30 children with growth hormone deficiency.

Authors:  V Kannan; K Usharani
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.